Delivery Order SPE2DB24D2010-SPE2DB25FAABV

Award Date 6/27/25
Potential Completion Date 6/30/25
Potential Value $7.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $7,061.07 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of June 4, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp also holds a $999,999,999.00 Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a medication used for the treatment of chronic obstructive pulmonary disease (COPD). The contract has a ceiling value of $21,469.41 and a period of performance through July 24, 2024. The contract is not designated as a set-aside....
This is a $5,036.81 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a medication used for the treatment of chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of January 24, 2025 and was awarded on January 23, 2025. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has a firm fixed price of $1,359.85 and a completion date of June 24, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen...
This is a $5,312.07 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The delivery order has an ultimate completion date of June 24, 2025 and is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a larger...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,476.50 contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S medication. The contract has an ultimate completion date of May 17, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRELEGY ELLIPTA 100-62.5-25 60S medication. The contract has a ceiling value of $12,107.78 and a completion date of June 12, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,967.29, is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a prescription medication. The contract has an ultimate completion date of March 27, 2025. This appears to be a component of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a $11,748.05 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a medication. The contract has an ultimate completion date of May 30, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,864.76, is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication product. The contract has an ultimate completion date of May 30, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
  • SPE2DB24D2010
    Indefinite Delivery Contract
  • SPE2DB24D2010-SPE2DB25FAABV
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,390.37 and is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of June 30, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard.

Generated 9/26/25, 9:54 AM